Abnormality in Coronary Slow Flow Phenomenon Detected by Nailfold Microcirculation Microanalysis
The coronary slow flow phenomenon (CSFP) is a clinical condition first described by Tambe et al. in 1972. It is characterized by delayed coronary blood flow in the absence of significant coronary artery stenosis, often leading to symptoms such as chest pain, myocardial ischemia, and even acute coronary syndrome. Despite its clinical significance, the diagnosis of CSFP has traditionally relied on invasive methods such as coronary angiography, specifically using the thrombolysis in myocardial infarction (TIMI) flow grade and the corrected TIMI frame count (CTFC). However, non-invasive diagnostic methods for CSFP remain limited. This study explores the potential of nailfold capillaroscopy as a non-invasive tool to detect abnormalities in the microcirculation of CSFP patients, providing new insights into the pathophysiology and diagnosis of this condition.
Background and Clinical Significance of CSFP
CSFP is observed in approximately 7% of patients undergoing coronary angiography for suspected coronary heart disease. It is defined by the slow opacification of the distal segments of otherwise normal epicardial coronary arteries, without evidence of ventricular dysfunction, connective tissue disorders, valvular heart diseases, or coronary spasm. The condition is associated with various risk factors, including male gender, smoking, dyslipidemia, metabolic syndrome, and obesity. The clinical presentation of CSFP often mimics that of obstructive coronary artery disease, making accurate diagnosis crucial for appropriate management.
The CTFC is a widely used method to quantify coronary flow velocity in CSFP patients. It measures the number of cine frames required for contrast dye to reach predefined distal landmarks in the coronary arteries. Higher CTFC values indicate slower coronary flow. While effective, this method is invasive and requires coronary angiography, which limits its applicability for routine monitoring and follow-up.
Nailfold Capillaroscopy: A Non-Invasive Diagnostic Tool
Nailfold capillaroscopy is a non-invasive imaging technique that allows for the visualization and analysis of the microvasculature in the nailfold region. It has been extensively used to study microvascular abnormalities in various rheumatic diseases, including systemic sclerosis, dermatomyositis, systemic lupus erythematosus, Sjögren syndrome, antiphospholipid syndrome, and familial Mediterranean fever. In 2014, Serkan et al. reported abnormalities in nailfold capillaries, such as dilatation, tortuosity, and microhemorrhages, in patients with CSFP, suggesting a potential link between systemic microvascular dysfunction and CSFP.
This study aimed to further investigate the utility of nailfold capillaroscopy in diagnosing CSFP by comparing nailfold capillary morphology, coronary angiography findings, and clinical parameters between CSFP patients and healthy controls. The study utilized a nailfold microcirculation microanalyzer to quantify capillary abnormalities and explore their correlation with CTFC values.
Study Design and Methodology
The study included 50 patients with CSFP and 50 healthy controls with normal coronary flow (NCF). Demographic characteristics and laboratory parameters were collected for both groups. The CSFP group had a higher proportion of active smokers compared to the NCF group, consistent with previous findings that smoking is a significant risk factor for CSFP.
Coronary angiography was performed in all patients, and CTFC values were calculated for the left anterior descending (LAD), right coronary artery (RCA), and left circumflex artery (LCX). The distribution of CSFP across these arteries was as follows: 76% of patients had CSFP in the LAD, 16% in the RCA, and 8% in the LCX. Additionally, 40% of patients had CSFP in both the LAD and RCA, 6% in the LAD and LCX, 2% in the RCA and LCX, and 22% in all three arteries. The CTFC values for all epicardial coronary arteries and the mean CTFC were significantly higher in the CSFP group compared to the NCF group, confirming the presence of slow coronary flow in the CSFP patients.
Nailfold Capillary Morphology in CSFP Patients
Nailfold capillary morphology was assessed using a microcirculation microanalyzer. The capillary loops in the NCF group were predominantly hairpin-shaped, straight, and parallel to the input and output branches, with a diameter ratio of 1:1.5. The blood vessels were clear, well-arranged, and evenly distributed. In contrast, the CSFP group exhibited similar capillary morphology, but with significantly thicker diameters of the input branch, output branch, and loop top compared to the NCF group. Specifically, the mean capillary diameter was larger in the CSFP group, with values of 0.023 mm for the input branch, 0.025 mm for the output branch, and 0.028 mm for the loop top, compared to 0.019 mm, 0.021 mm, and 0.023 mm, respectively, in the NCF group.
Capillary morphology abnormalities, including tortuosity and dilatation, were observed in 24% of CSFP patients and 18% of NCF patients, though the difference was not statistically significant. Notably, no microhemorrhages were detected in either group. The study found a strong positive correlation between mean CTFC and capillary diameter in the CSFP group, with a correlation coefficient of 0.9518, indicating that capillary diameter increases as coronary flow velocity decreases.
Diagnostic Utility of Nailfold Capillaroscopy
Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of nailfold capillary diameter in detecting CSFP. The area under the curve (AUC) was 0.7852, suggesting that nailfold capillary diameter has moderate diagnostic accuracy for CSFP. This finding supports the use of nailfold capillaroscopy as a non-invasive tool for evaluating microvascular abnormalities in CSFP patients.
Pathophysiological Implications
The observed capillary dilatation in CSFP patients may represent a compensatory mechanism to maintain tissue blood supply and oxygen delivery in the setting of reduced coronary flow. This hypothesis aligns with previous studies that have linked systemic microvascular dysfunction to CSFP. The strong correlation between capillary diameter and CTFC further underscores the potential role of microvascular abnormalities in the pathophysiology of CSFP.
Clinical Applications and Future Directions
The findings of this study have significant clinical implications. Nailfold capillaroscopy offers a simple, non-invasive, and cost-effective method for diagnosing and monitoring CSFP. It can be used in routine clinical practice to assess microvascular abnormalities and guide therapeutic interventions. Additionally, the technique may be useful for evaluating the efficacy of treatments aimed at improving coronary microvascular function.
Future research should focus on validating these findings in larger, multicenter studies and exploring the underlying mechanisms linking nailfold capillary abnormalities to CSFP. Longitudinal studies are also needed to determine whether nailfold capillaroscopy can predict clinical outcomes in CSFP patients, such as the risk of myocardial infarction or acute coronary syndrome.
Conclusion
This study demonstrates that nailfold capillaroscopy is a promising non-invasive tool for detecting microvascular abnormalities in patients with CSFP. The technique provides valuable insights into the pathophysiology of CSFP and offers a convenient alternative to invasive diagnostic methods. By enabling routine monitoring of microvascular function, nailfold capillaroscopy has the potential to improve the diagnosis and management of CSFP, ultimately enhancing patient outcomes.
doi.org/10.1097/CM9.0000000000001437
Was this helpful?
0 / 0